Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Lansoprazole
|
| gptkbp:activities |
inhibits gastric acid secretion
|
| gptkbp:appointed_by |
oral capsule
|
| gptkbp:approves |
gptkb:2009
gptkb:FDA |
| gptkbp:brand |
gptkb:Dexilant
|
| gptkbp:category |
Category B
|
| gptkbp:class |
gptkb:railway_station
|
| gptkbp:clinical_trial |
short-term treatment
studies for long-term safety long-term management of GERD studies for efficacy in erosive esophagitis studies for pediatric use |
| gptkbp:contraindication |
hypersensitivity to dexlansoprazole
|
| gptkbp:counseling_services |
report any unusual symptoms to a doctor
take before meals do not crush or chew capsules may take up to 4 weeks for full effect |
| gptkbp:dosage_form |
60 mg once daily
30 mg once daily delayed-release capsule |
| gptkbp:excretion |
urine
|
| gptkbp:formulation |
gptkb:beer
gptkb:tablet |
| https://www.w3.org/2000/01/rdf-schema#label |
Dexlansoprazole
|
| gptkbp:indication |
erosive esophagitis
symptomatic GERD |
| gptkbp:ingredients |
C18 H19 N3 O3 S
|
| gptkbp:interacts_with |
gptkb:methotrexate
gptkb:clopidogrel gptkb:warfarin |
| gptkbp:is_atype_of |
A02 B C05
|
| gptkbp:is_available_on |
over-the-counter
|
| gptkbp:is_used_for |
treatment of gastroesophageal reflux disease (GERD)
|
| gptkbp:lifespan |
approximately 1 hour
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:Takeda_Pharmaceuticals
|
| gptkbp:metabolism |
liver
|
| gptkbp:side_effect |
gptkb:healthcare_organization
headache nausea abdominal pain diarrhea liver dysfunction bone fractures vitamin B12 deficiency gastrointestinal infections |